Discover trends, market shifts, and competitive outlooks for the cardiac biomarkers industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Anticipated CAGR of the Cardiac Biomarkers Market, and What Factors Will Drive It?

In recent years, the cardiac biomarkers market has seen rapid expansion. Its forecasted growth projects an increase from $18.99 billion in 2024 to $21.32 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.3%. Factors contributing to this growth during the historic period include elevated healthcare spending, FDA authorizations as well as regulatory backing, an aging demographic, educational initiatives, widespread use of highly sensitive troponin tests, and a rise in cardiovascular diseases.

The market for cardiac biomarkers is predicted to experience swift expansion in the coming years. With a compound annual growth rate (CAGR) of 14.4%, the market is projected to reach $36.51 billion in 2029. The expected growth during this period can be linked to the increasing prevalence of chronic illnesses, the heightened emphasis on early diagnosis of diseases, the growing size of the elderly population, advancements in emerging markets, and the focus on biomarker panels. Notable trends expected during this forecast period include the adoption of patient-focused healthcare models, the application of AI and machine learning, the integration of digital health, technological advancements in biomarker discovery, multi-marker panels, and the use of liquid biopsy in cardiovascular medicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10234&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Cardiac Biomarkers Market?

The increasing incidence of cardiovascular diseases is anticipated to drive the expansion of the cardiac biomarker market. Cardiovascular diseases, which encompass conditions like coronary artery disease, heart failure, and stroke, impact the heart and the blood vessels. Cardiac biomarkers, substances that are secreted into the bloodstream due to specific cardiovascular ailments including myocardial infarction (heart attack), heart failure, and arrhythmias, can be quantified using laboratory tests, offering critical diagnostic and prognostic data. For example, in September 2024, information released by the British Heart Foundation, a UK-based cardiovascular research charity, revealed that in the UK, about 7.6 million individuals suffer from heart and circulatory disorders, including nearly 4 million men and 3.6 million women. These diseases account for approximately 27% of UK’s total fatalities, equivalent to over 170,000 deaths per year, or about 480 deaths daily, resulting in one death every three minutes. As a result, the growing incidence of these cardiovascular ailments is fostering the expansion of the cardiac biomarker market.

Which Primary Segments of the Cardiac Biomarkers Market Are Driving Growth and Industry Transformations?

The cardiac biomarkers market covered in this report is segmented –

1) By Biomarkers Type: Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarker Types

2) By Location Of Testing: Point Of Care Testing, Laboratory Testing

3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications

4) By End User: Hospitals, Specialty Clinics

Subsegments:

1) By Creatine Kinase (CK-Mb): CK-Mb Test Kits, CK-Mb Diagnostic Panels

2) By Troponins: Troponin I Test Kits, Troponin T Test Kits, Troponin Diagnostic Panels

3) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

4) By Natriuretic Peptides (BNP And NT-proBNP): BNP Test Kits, NT-ProBNP Test Kits, Natriuretic Peptides Diagnostic Panels

5) By Ischemia Modified Albumin (IMA): IMA Test Kits, IMA Diagnostic Panels

6) By Other Biomarker Types: Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP), Other Emerging Biomarkers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10234&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Cardiac Biomarkers Market?# Market?

North America was the largest region in the cardiac biomarkers market in 2024. The regions covered in the cardiac biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Most Significant Market Trends in the Cardiac Biomarkers Market?

The rising trends in the cardiac biomarker market are largely influenced by technological innovations. In an effort to maintain their market positions, businesses in this sector are leveraging new technologies. As an example, Mindray, a medical devices company headquartered in China, launched innovative high-sensitivity cardiac biomarkers – troponin I (hs-cTnI) and NT-proBNP – in October 2023. These were specifically designed to boost the identification and treatment processes for cardiovascular diseases (CVDs). The hs-cTnI biomarker is particularly significant for diagnosing myocardial injury due to its high detection rate and precise results, making it the perfect tool for early screenings and risk evaluations especially in cases such as Acute Coronary Syndrome (ACS). Conversely, NT-proBNP is a trusted biomarker used for diagnosing heart failure, enhancing its detection and management while consistently delivering precise results and showing minimal interaction with commonly prescribed heart medications. These biomarkers as a collective significantly transform clinical decision-making in emergency cardiovascular care.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

What Parameters Are Used to Define the Cardiac Biomarkers Market?

Cardiac biomarkers are chemicals released by heart into the blood when it is injured or under stress. It used for the detection and measurement of various cardiac vascular diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10234

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model